HUP0003159A3 - The use of n-monosubstituted-3-oxo-4-aza-5alpha-androst-1-en-17betha-carboxamides for the preparation of pharmaceutical compositions - Google Patents

The use of n-monosubstituted-3-oxo-4-aza-5alpha-androst-1-en-17betha-carboxamides for the preparation of pharmaceutical compositions

Info

Publication number
HUP0003159A3
HUP0003159A3 HU0003159A HUP0003159A HUP0003159A3 HU P0003159 A3 HUP0003159 A3 HU P0003159A3 HU 0003159 A HU0003159 A HU 0003159A HU P0003159 A HUP0003159 A HU P0003159A HU P0003159 A3 HUP0003159 A3 HU P0003159A3
Authority
HU
Hungary
Prior art keywords
17betha
5alpha
androst
carboxamides
monosubstituted
Prior art date
Application number
HU0003159A
Other languages
English (en)
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of HUP0003159A2 publication Critical patent/HUP0003159A2/hu
Publication of HUP0003159A3 publication Critical patent/HUP0003159A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HU0003159A 1997-07-29 1998-07-27 The use of n-monosubstituted-3-oxo-4-aza-5alpha-androst-1-en-17betha-carboxamides for the preparation of pharmaceutical compositions HUP0003159A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20313697 1997-07-29
PCT/JP1998/003337 WO1999006050A1 (fr) 1997-07-29 1998-07-27 Agent reparateur contre la calvitie et autres maladies

Publications (2)

Publication Number Publication Date
HUP0003159A2 HUP0003159A2 (hu) 2001-04-28
HUP0003159A3 true HUP0003159A3 (en) 2001-07-30

Family

ID=16469018

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0003159A HUP0003159A3 (en) 1997-07-29 1998-07-27 The use of n-monosubstituted-3-oxo-4-aza-5alpha-androst-1-en-17betha-carboxamides for the preparation of pharmaceutical compositions

Country Status (22)

Country Link
US (1) US6380179B1 (hu)
EP (1) EP0998930B1 (hu)
KR (1) KR20010022066A (hu)
CN (1) CN1129433C (hu)
AT (1) ATE262337T1 (hu)
AU (1) AU733830B2 (hu)
BR (1) BR9811293A (hu)
CA (1) CA2298851A1 (hu)
DE (1) DE69822636T2 (hu)
DK (1) DK0998930T3 (hu)
ES (1) ES2218840T3 (hu)
HK (1) HK1027290A1 (hu)
HU (1) HUP0003159A3 (hu)
ID (1) ID24566A (hu)
IL (1) IL134199A0 (hu)
NO (1) NO20000469L (hu)
NZ (1) NZ502537A (hu)
PL (1) PL338414A1 (hu)
PT (1) PT998930E (hu)
RU (1) RU2193887C2 (hu)
TR (1) TR200000263T2 (hu)
WO (1) WO1999006050A1 (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL335365A1 (en) * 1997-02-26 2000-04-25 Sankyo Co Composition for treating or preventing prostatic carcinoma
WO2005074985A2 (en) * 2004-02-02 2005-08-18 Schering Corporation Methods of modulating cd200 and cd200r
US20080108681A1 (en) * 2006-10-27 2008-05-08 Access Business Group International Llc Use of allantoin as a pro-collagen synthesis agent in cosmetic compositions
US20120245205A1 (en) 2009-07-29 2012-09-27 Delong Mitchell A Compositions and methods for inhibiting hair growth
MX2010012945A (es) * 2010-11-24 2012-05-24 Fidel Ojeda Gomez Una formula para el control y eliminacion de seborrea y alopecia en el cuero cabelludo.
RU2477155C2 (ru) * 2011-04-27 2013-03-10 Закрытое акционерное общество "Патент-Фарм" Способ лечения андрогенетической алопеции

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571817A (en) 1984-02-27 1996-11-05 Merck & Co., Inc. Methods of treating androgenic alopecia with finasteride [17β-N-mono-substituted-carbamoyl-4-aza-5-α-androst-1-en-ones]
US5516768A (en) 1990-03-16 1996-05-14 Smithkline Beecham Corporation Uncompetitive inhibition of steroid and 5α-reductose
IE76452B1 (en) 1990-10-29 1997-10-22 Sankyo Co Azasteroid compounds for the treatment of prostatic hypertrophy their preparation and use
JP3030152B2 (ja) * 1992-02-03 2000-04-10 三共株式会社 4−アザステロイド化合物
TW382595B (en) 1993-10-15 2000-02-21 Merck & Co Inc Pharmaceutical composition for use in arresting and reversing androgenic alopecia
JPH0873492A (ja) * 1994-06-28 1996-03-19 Sankyo Co Ltd アザステロイド類
US5629007A (en) 1995-03-21 1997-05-13 Eli Lilly And Company Method of preventing prostatic cancer development
US5635197A (en) 1995-03-21 1997-06-03 Eli Lilly And Company Treatment and prevention of prostatic cancer metastasis
AU7078296A (en) 1995-09-27 1997-04-17 Merck & Co., Inc. Method of preventing androgenetic alopecia with 5-alpha reductase inhibitors
NZ326897A (en) * 1996-02-05 1999-08-30 Sankyo Co 5 <alpha>-reductase inhibitory preparation for oral administration, process for producing the same, and use thereof
US6093722A (en) 1997-02-26 2000-07-25 Sankyo Company, Limited Method for treating prostate cancer
PL335365A1 (en) * 1997-02-26 2000-04-25 Sankyo Co Composition for treating or preventing prostatic carcinoma

Also Published As

Publication number Publication date
WO1999006050A1 (fr) 1999-02-11
TR200000263T2 (tr) 2000-09-21
ID24566A (id) 2000-07-27
CN1129433C (zh) 2003-12-03
PT998930E (pt) 2004-05-31
CA2298851A1 (en) 1999-02-11
HUP0003159A2 (hu) 2001-04-28
IL134199A0 (en) 2001-04-30
BR9811293A (pt) 2000-08-29
NO20000469L (no) 2000-03-28
AU8358598A (en) 1999-02-22
ATE262337T1 (de) 2004-04-15
AU733830B2 (en) 2001-05-24
DE69822636T2 (de) 2005-01-05
DK0998930T3 (da) 2004-04-26
US6380179B1 (en) 2002-04-30
PL338414A1 (en) 2000-11-06
DE69822636D1 (de) 2004-04-29
EP0998930A1 (en) 2000-05-10
NO20000469D0 (no) 2000-01-28
CN1271285A (zh) 2000-10-25
EP0998930A4 (en) 2002-06-12
ES2218840T3 (es) 2004-11-16
HK1027290A1 (en) 2001-01-12
KR20010022066A (ko) 2001-03-15
EP0998930B1 (en) 2004-03-24
NZ502537A (en) 2002-11-26
RU2193887C2 (ru) 2002-12-10

Similar Documents

Publication Publication Date Title
HK1025904A1 (en) Pharmaceutical composition for combination of piperidinoalkanol-decongestant
GB9727053D0 (en) Pharmaceutical compositions
GB9706089D0 (en) Pharmaceutical composition
CY2569B1 (en) Pharmaceutical compositions
GB9717444D0 (en) Pharmaceutical composition
IL131995A0 (en) Gastric-retained pharmaceutical compositions
GB9723985D0 (en) Pharmaceutical compositions
GB9717428D0 (en) Pharmaceutical composition
HUP0004669A3 (en) Pharmaceutical compositions
HUP0003159A3 (en) The use of n-monosubstituted-3-oxo-4-aza-5alpha-androst-1-en-17betha-carboxamides for the preparation of pharmaceutical compositions
HUP9901969A3 (en) Use of n-mercaptoalkanoyl-cysteine derivatives for the preparation of pharmaceutical compositions traiting ischemia
HU9700632D0 (en) Pharmaceutical compositions
HUP0001441A3 (en) Process for the preparation of pharmaceutical compositions containing 4-aza-androst-1-ene derivatives
HUP0200311A3 (en) Use of aroyl- or arylalkanoylpyridazines for preparation of pharmaceutical compositions
GB9717770D0 (en) Pharmaceutical composition
GB9921495D0 (en) Pharmaceutical compositions
GB2321190B (en) Pharmaceutical composition
GB9726781D0 (en) Pharmaceutical composition
HUP0001697A3 (en) Benzopyranopyrrole and benzopyranopyridine derivatives, pharmaceutical compositions thereof, preparation and use of the compounds
HUP0004274A3 (en) Bispyrido-cycloheptane compounds and pharmaceutical compositions thereof
IL134562A0 (en) Use of non-immunosuppressive compounds for the preparation of pharmaceutical compositions
GB9710527D0 (en) Pharmaceutical compositions
GB9718270D0 (en) Pharmaceutical compositions
GB9710505D0 (en) Pharmaceutical compositions
GB9714328D0 (en) Pharmaceutical compositions